More finely tuned view of ankylosing spondylitis leads to better treatment, expert says
ACR Winter Rheumatology Symposium
The American College of Rheumatology’s upcoming Winter Rheumatology Symposium will be held in Snowmass Village, Colorado from January 26 — February 1, 2013.
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
A Few Acronyms and Indices in OMERACT
HAQ: Health Assessment Questionnaire DAS28: Disease Activity Score DAS: Psoriatic Arthritis: ACR Core Data Set and Disease Activity Score PsARC: Psoriatic Arthritis Response Criteria PSAI: Psoriasis Area and Severity Index SLEDAI: SLE Disease Activity Score BILAG: British Isles Lupus Activity Score SLAM: Systemic Lupus Activity Measure LAI: Lupus Activity Index ECLAM: European Consensus Lupus Activity…
How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases
Studying the relationships between microbes and their hosts, the role for Bacille Calmette Guerin (BCG) as a vaccine for Type I diabetes, and emotional stress and bone metastases
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
EULAR 2012: Does Arthritis Start in the Gut?
New research on the ties between bacteria and inflammatory disease.
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- Next Page »